An investor in two large Bay State health care companies involved in separate mergers said he doesn’t expect the U.S. Treasury’s recently announced measures aimed at cracking down on corporate tax inversions to derail those plans, the Boston Business Journal reported.
Tech Collective, an industry association for information technology and bioscience, has announced a call for applicants for its 2014 Rhode Island Bioscience Awards, the program’s second year following its launch in 2013.
U.S. stocks fell a second day from record levels, with the Nasdaq Composite Index tumbling the most since April, as investors sold Internet and biotechnology shares before the start of earnings season.
By Sofia Horta e Costa and Joseph Ciolli Bloomberg News
The biosciences comprise a burgeoning industry and important opportunity for Rhode Island. The state’s bioscience industry employs 4,602 bioscience professionals and has a total employment impact of an additional 11,847 workers. On a national and global scale, Rhode Island bioscience companies and professionals participate in the industry’s five primary sectors: drugs and pharmaceuticals; medical devices and equipment; research, testing, and medical laboratories; agricultural feedstock and chemicals; and bioscience-related distribution.
Estate and Corporate Income Taxes are changing next year, and business owners and executives should know the details. The PBN Summit on November 6th will provide those details and more - including how much Obamacare's Employer Mandate could cost.
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.